Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis

被引：0

作者：

Martin Orban

Jan Kleeberger

Taoufik Ouarrak

Anne Freund

Hans-Josef Feistritzer

Georg Fuernau

Tobias Geisler

Kurt Huber

Dariusz Dudek

Marko Noc

Gilles Montalescot

Alexander Neumer

Paul Haller

Peter Clemmensen

Uwe Zeymer

Steffen Desch

Steffen Massberg

Steffen Schneider

Holger Thiele

Jörg Hausleiter

机构：

[1] University Hospital,Department of Medicine I

[2] Ludwig-Maximilians-University,German Center for Cardiovascular Research (DZHK), Partner Site Munich

[3] Munich Heart Alliance,Medical Faculty, 3rd Department of Medicine, Cardiology and Intensive Care Medicine

[4] Stiftung Institut für Herzinfarktforschung,Medizinische Klinik und Poliklinik I

[5] Heart Center Leipzig at University of Leipzig,undefined

[6] University Heart Center Lübeck,undefined

[7] University Hospital of Tübingen,undefined

[8] Wilhelminenhospital,undefined

[9] and Sigmund Freud University,undefined

[10] Jagiellonian University,undefined

[11] University Medical Center Ljubljana,undefined

[12] Sorbonne Université,undefined

[13] ACTION Group,undefined

[14] Hôpital Pitié-Salpêtrière (AP-HP),undefined

[15] Universitäres Herz- Und Gefäßzentrum UKE Hamburg,undefined

[16] LMU Klinikum München,undefined

[17] Campus Großhadern,undefined

[18] Ludwig-Maximilians-Universität München,undefined

来源：

Clinical Research in Cardiology | 2021年 / 110卷

关键词：

Clopidogrel; Prasugrel; Ticagrelor; ADP-receptor antagonists; Cardiogenic shock; Bleeding;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1493 / 1503

页数：10

共 50 条

[31] Right Ventricular Dysfunction in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Hemodynamic Analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial and Registry
Lala, Anuradha
Ma, Yu Guo
Xu, Jinfeng
Esposito, Michele
Morine, Kevin
Karas, Richard
Katz, Stuart D.
Hochman, Judith S.
Burkhoff, Daniel
Kapur, Navin K.
JOURNAL OF CARDIAC FAILURE, 2018, 24 (03) : 148 - 156
[32] Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial a infarction cardiogenic shock
Vallabhajosyula, Saraschandra
Verghese, Dhiran
Bell, Malcolm R.
Murphree, Dennis H.
Cheungpasitporn, Wisit
Miller, Paul Elliott
Dunlay, Shannon M.
Prasad, Abhiram
Sandhu, Gurpreet S.
Gulati, Rajiv
Singh, Mandeep
Lerman, Amir
Gersh, Bernard J.
Holmes, David R., Jr.
Barsness, Gregory W.
ESC HEART FAILURE, 2021, 8 (03): : 2025 - 2035
[33] Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study
Chang, Chi-Jen
Tung, Ying-Chang
Liu, Jia-Rou
Chang, Shu-Hao
Kuo, Chi-Tai
See, Lai-Chu
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (02) : 443 - 451
[34] Multivessel vs. culprit-vessel only percutaneous coronary interventions in acute myocardial infarction and cardiogenic shock: a systematic review and meta-analysis of prospective randomized and retrospective studies
Gill, Gauravpal S.
Sanchez, Jorge Sanz
Thandra, Abhishek
Kanmanthareddy, Arun
Alla, Venkata Mahesh
Garcia-Garcia, Hector M.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2022, 11 (07) : 558 - 569
[35] Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes
Ghajar, Alireza
Ordonez, Cesar Palacios
Philips, Binu
Pinzon, Pablo Quintero
Fleming, Lisa M.
Motiwala, Shweta R.
Sriwattanakomen, Roy
Ho, Jennifer E.
Grandin, E. Wilson
Sabe, Marwa
Garan, Arthur Reshad
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 367 : 45 - 48
[36] Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis
Kundu, Amartya
Sardar, Partha
Kakouros, Nikolaos
Malhotra, Rohit
Kolte, Dhaval
Feldman, Dmitriy N.
Abbott, J. D.
Fisher, Daniel Z.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (01) : 70 - 81
[37] Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial
Motovska, Zuzana
Hlinomaz, Ota
Mrozek, Jan
Kala, Petr
Geisler, Tobias
Hromadka, Milan
Akin, Ibrahim
Precek, Jan
Kettner, Jiri
Cervinka, Pavel
Montalescot, Gilles
Jarkovsky, Jiri
Belohlavek, Jan
Bis, Josef
Matejka, Jan
Vodzinska, Alexandra
Muzafarova, Tamilla
Tomasov, Pavol
Schee, Alexander
Bartus, Stanislav
Andrasova, Andrea
Olivier, Christoph B.
Kovarik, Ales
Ostadal, Petr
Demlova, Regina
Souckova, Lenka
Vulev, Ivan
Coufal, Zdenek
Kochman, Janusz
Marinov, Iuri
Kubica, Jacek
Ducrocq, Gregory
Karpisek, Michal
Klimsa, Zdenek
Hudec, Martin
Widimsky, Petr
Bhatt, Deepak L.
EUROINTERVENTION, 2024, 20 (20) : e1309 - e1318
[38] Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry
Dzavik, V
Steeper, LA
Cocke, TP
Moscucci, M
Saucedo, J
Hosat, S
Jiang, X
Slater, J
LeJemtel, T
Hochman, JS
EUROPEAN HEART JOURNAL, 2003, 24 (09) : 828 - 837
[39] Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
Kim, Byung Gyu
Hong, Sung-Jin
Kim, Byeong-Keuk
Lee, Yong-Joon
Lee, Seung-Jun
Ahn, Chul-Min
Shin, Dong-Ho
Kim, Jung-Sun
Ko, Young-Guk
Choi, Donghoon
Hong, Myeong-Ki
Jang, Yangsoo
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[40] In-hospital outcomes of acute myocardial infarction with cardiogenic shock caused by right coronary artery occlusion vs. left coronary artery occlusion
Taniguchi Y.
Sakakura K.
Adachi Y.
Akashi N.
Watanabe Y.
Noguchi M.
Yamamoto K.
Ugata Y.
Wada H.
Momomura S.-I.
Fujita H.
Cardiovascular Intervention and Therapeutics, 2018, 33 (4) : 338 - 344

← 1 2 3 4 5 →